Connect Biopharma Hldgs Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB), Aethlon Medical (AEMD) and Aclaris Therapeutics (ACRS)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Connect Biopharma Holdings (CNTB) and Inspire Medical Systems (INSP)
Cantor Fitzgerald Reiterates Overweight on Connect Biopharma Hldgs, Maintains $5 Price Target
Connect Biopharma Hldgs Analyst Ratings
SVB Securities Remains a Buy on Connect Biopharma Holdings (CNTB)
SVB Securities Adjusts Connect Biopharma Price Target to $7 From $9, Maintains Outperform Rating
Connect Biopharma Hldgs Analyst Ratings
SVB Leerink Maintains Outperform on Connect Biopharma Hldgs, Lowers Price Target to $7
Connect Biopharma Holdings (CNTB) Receives a Buy From Jefferies
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ascendis Pharma (ASND), Rubius Therapeutics (RUBY) and Connect Biopharma Holdings (CNTB)
Piper Sandler Adjusts Price Target on Connect Biopharma Holdings to $1.75 From $1.50, Maintains Neutral Rating
SVB Securities Thinks Connect Biopharma Holdings' Stock is Going to Recover
Connect Biopharma Price Target Announced at $5.00/Share by Cantor Fitzgerald
Connect Biopharma Initiated at Overweight by Cantor Fitzgerald
Cantor Fitzgerald Starts Connect Biopharma Holdings at Overweight With $5 Price Target
Connect Biopharma Hldgs analyst ratings
Cantor Fitzgerald Initiates Coverage On Connect Biopharma Hldgs with Overweight Rating, Announces Price Target of $5
No Data